Overview

Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of sertraline in reducing symptoms in women diagnosed with premenstrual dysphoric disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Sertraline